The breath-test technology relies on the idea that the biology of tumours can lead to the production of specific "volatile organic compounds", combinations of chemicals unlikely in a healthy person.
Transforming biology into an engineering practice, decoupling design from fabrication and speeding the biological design, build, test cycle is how DARPA proposes to tackle this problem.